StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$161.52+0.73 (+0.45%)

Close on Nov 2, 2026Market cap $308.21BP/E 22.6Yield –

Novartis Pretax Income by Quarter

Pretax Income ($M)

QuarterlyAnnual

Novartis Pretax Income: $1,317M in Q3 2026, down 68.6% from a year earlier. That is the lowest of the 37 quarters on record here.

Latest, Q3 2026
1,317
Period ended Sep 30, 2026
Change on a year earlier
-68.6%
4,196 in Q3 2025
History
37 quarters
Since Q2 2017
Sources
32
Documents cited below

Where the Q3 2026 figure comes from

“|| Income before taxes | 1 317 | 4 196”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Postgres DB + Form 6-K.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedPretax Income ($M)Year on yearSource
Q3 2026Sep 30, 20261,317-68.6%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 20264,269-5.8%Novartis 6-K (0001114448-26-000012, filed 2026-07-21) ↗
Q1 2026Mar 31, 20263,839-12.9%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 20253,218-2.0%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 20254,196+24.0%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2025Jun 30, 20254,531+18.0%Novartis 6-K (0001370368-25-000012, filed 2025-07-17) ↗
Q1 2025Mar 31, 20254,407+40.8%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2024Dec 31, 20243,285+38.2%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2024Sep 30, 20243,385+118.1%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2024Jun 30, 20243,841+43.6%Novartis 6-K (0001370368-24-000019, filed 2024-07-18) ↗
Q1 2024Mar 31, 20243,129+24.2%Novartis Form 6-K (0001370368-25-000010) ↗
Q4 2023Dec 31, 20232,377+51.5%Novartis Form 6-K (0001370368-25-000007) ↗
Q3 2023Sep 30, 20231,552-2.2%Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2023Jun 30, 20232,674+31.0%Novartis 6-K (0001370368-24-000019, filed 2024-07-18) ↗
Q1 2023Mar 31, 20232,520-5.6%Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2022Dec 31, 20221,569-90.7%Novartis Form 6-K (0001370368-24-000007) ↗

Cite this data

StockData. (2026). Novartis Pretax Income ($M), quarterly Q2 2017–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-is-pretax

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.